4.0500
-0.4500
(-10.00%)
As of 12:06:35 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -2.65 | -2.67 | -9.3 | -7.74 |
| Low Estimate | -2.8 | -2.83 | -11.37 | -12.25 |
| High Estimate | -2.43 | -2.53 | -6.92 | -5.46 |
| Year Ago EPS | -3 | -2.75 | -11 | -9.3 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -3.1 | -3.1 | -3.17 | -2.76 |
| EPS Actual | -3 | -2.75 | -2.78 | -3 |
| Difference | 0.1 | 0.35 | 0.39 | -0.24 |
| Surprise % | 3.23% | 11.15% | 12.21% | -8.70% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.65 | -2.67 | -9.3 | -7.74 |
| 7 Days Ago | -2.79 | -2.78 | -6.43 | -4.55 |
| 30 Days Ago | -2.79 | -2.78 | -6.43 | -4.55 |
| 60 Days Ago | -2.79 | -2.78 | -9.29 | -4.55 |
| 90 Days Ago | -2.79 | -2.78 | -9.29 | -4.55 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | 1 | -- | -- | 1 |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KZR | 11.67% | 3.06% | 15.45% | 16.83% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 12/19/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 12/2/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 10/18/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 10/14/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 10/2/2024 |
Related Tickers
THRD Third Harmonic Bio, Inc.
3.3850
-5.18%
PMVP PMV Pharmaceuticals, Inc.
0.9600
-3.52%
ANTX AN2 Therapeutics, Inc.
1.2900
-7.86%
HLVX HilleVax, Inc.
1.4400
-0.69%
NXTC NextCure, Inc.
0.3900
-1.76%
EPIX ESSA Pharma Inc.
1.5200
-3.80%
IPSC Century Therapeutics, Inc.
0.4301
-6.30%
SPRO Spero Therapeutics, Inc.
0.5968
-4.36%
RPTX Repare Therapeutics Inc.
1.0100
-3.81%
ASMB Assembly Biosciences, Inc.
8.72
-6.34%